Related Experiment Videos
Prothrombin G20210A mutation in a child with spinal cord infarction
G Young1, K A Krohn, R J Packer
1Departments of Hematology/Oncology and Neurology, Children's National Medical Center, George Washington University, Washington, DC., USA.
The Journal of Pediatrics
|June 4, 1999
Summary
The prothrombin G20210A mutation increases thrombosis risk. A child with this mutation experienced a spinal cord infarct, highlighting its potential impact even without other risk factors.
Area of Science:
- Genetics
- Hematology
- Neurology
Background:
- The prothrombin G20210A mutation is a recently identified genetic factor linked to a higher likelihood of developing blood clots.
- Understanding the clinical significance of this mutation in pediatric populations is crucial for risk assessment.
Observation:
- A previously healthy child was found to be heterozygous for the prothrombin G20210A mutation.
- The child presented with a spinal cord infarct, a serious thrombotic event.
Findings:
- The spinal cord infarct occurred in the absence of any other identifiable prothrombotic risk factors.
- This case suggests the prothrombin G20210A mutation may be a significant independent risk factor for thrombosis in children.
Implications:
- This finding underscores the importance of considering genetic prothrombotic mutations in the etiological workup of pediatric thrombosis.
- Further research is warranted to elucidate the precise mechanisms and prevalence of prothrombin G20210A-associated thrombosis in children.